The World Health Organization set off some alarm bells this weekend when the agency warned against issuing coronavirus "immunity passports" because there's no evidence to suggest people are protected from second infections. Some people weren't so sure, even dismissing reports on the announcement as fear-mongering.
But the confusion may stem from a lack of context in reports about coronavirus reinfection or reactivation in presumably recovered patients coming out China and South Korea. For starters, there's the possibility of false negative test results, which could register as positives at a later date. It's also not always known if the patients testing positive again are showing new symptoms.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
How to figure out when your tax refund will arriveThe explainer How long do you have to wait between submitting your return and receiving the money?
-
'It also means the start of a virtuous ecological cycle'Instant Opinion Opinion, comment and editorials of the day
-
Canada beats US in charged 4 Nations hockey finalSpeed Read 'You can't take our country — and you can't take our game,' Prime Minister Justin Trudeau posted after the game
-
Ozempic can curb alcohol cravings, study findsSpeed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
-
New form of H5N1 bird flu found in US dairy cowsSpeed Read This new form of bird flu is different from the version that spread through herds in the last year
-
Microplastics accumulating in human brains, study findsSpeed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
-
FDA approves painkiller said to thwart addictionSpeed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
-
Study finds possible alternative abortion pillSpeed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
-
California declares bird flu emergencySpeed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
-
Bird flu one mutuation from human threat, study findsSpeed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
-
Dark chocolate tied to lower diabetes riskSpeed Read The findings were based on the diets of about 192,000 US adults over 34 years
